Brinzolamide
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Brinzolamide?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Brinzolamide (trade name Azopt) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
This article needs additional citations for verification. (October 2017) |
Quick Facts Clinical data, Pronunciation ...
Clinical data | |
---|---|
Pronunciation | brin ZOH la mide |
Trade names | Azopt |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601233 |
License data |
|
Pregnancy category |
|
Routes of administration | Ophthalmic |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Absorbed systemically, but below detectable levels (less than 10 ng/mL) |
Protein binding | ~60% |
Elimination half-life | 111 days |
Excretion | Kidney (60%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.149.376 |
Chemical and physical data | |
Formula | C12H21N3O5S3 |
Molar mass | 383.50 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close
Brinzolamide was approved as a generic medication in the United States in November 2020.[2]